Show items per page
Elements: 3
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis Bone, Henry G; Cosman, Felicia; Miller, Paul D; Williams, Gregory C; ... Saag, Kenneth G 2018
add to browser selection
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis McClung, Michael R; Boonen, Steven; Törring, Ove; Roux, Christian; ... Cummings, Steven R 2012
add to browser selection
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect Eisman, John A; Bone, Henry G; Hosking, David J; McClung, Michael R; ... Lombardi, Antonio 2011